Items where Author is "Altmann, DR"
Number of items: 148.
Bibliographic data only
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis. (2013)
Altmann, DR; Button, T; Schmierer, K; Hunter, K; Tozer, DJ; Wheeler-Kingshott, CA; Coles, A; Miller, DH
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. (2008)
Altmann, DR; Jasperse, B; Barkhof, F; Beckmann, K; Filippi, M; Kappos, LD; Molyneux, P; Polman, CH; Pozzilli, C; Thompson, AJ; Wagner, K; Yousry, TA; Miller, DH
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis-Sormani et al., Neurology 77, 2011. (2012)
Altmann, Dan R
Effects of an MRI scanner upgrade on longitudinal measures of brain atrophy and application of a statistical correction method. (2007)
Anderson, VM; Altmann, DR; Fisniku, L; Fox, NC; Miller, DH
Reduced cerebellar grey matter volume is associated with cerebellar dysfunction in multiple sclerosis. (2008)
Anderson, VM; Fisniku, LK; Altmann, D; Chard, DT; Thompson, AJ; Miller, DH
MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction. (2009)
Anderson, VM; Fisniku, LK; Altmann, DR; Thompson, AJ; Miller, DH
Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. (2010)
Anderson, VM; Fisniku, LK; Khaleeli, Z; Summers, MM; Penny, SA; Altmann, DR; Thompson, AJ; Ron, MA; Miller, DH
Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. (2006)
Bieniek, M; Altmann, DR; Davies, GR; Ingle, GT; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Miller, DH
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. (2010)
Bonati, U; Fisniku, LK; Altmann, DR; Yiannakas, MC; Furby, J; Thompson, AJ; Miller, DH; Chard, DT
Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. (2009)
Brasil Caseiras, Gisele; Ciccarelli, Olga; Altmann, Daniel R; Benton, Christopher E; Tozer, Daniel J; Tofts, Paul S; Yousry, Tarek A; Rees, Jeremy; Waldman, Adam D; Jäger, Hans Rolf
Alcohol consumption and stroke: difficulties in assessing the relationships. (2002)
Britton, Annie; Mazzaglia, Giampiero; Altmann, Daniel
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab. (2012)
Button, Tom; Altmann, Dan; Tozer, Dan; Dalton, Catherine; Hunter, Kelvin; Compston, Alastair; Coles, Alasdair; Miller, David
The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. (2003)
Chard, DT; Brex, PA; Ciccarelli, O; Griffin, CM; Parker, GJM; Dalton, C; Altmann, DR; Thompson, AJ; Miller, DH
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. (2004)
Chard, DT; Griffin, CM; Rashid, W; Davies, GR; Altmann, DR; Kapoor, R; Barker, GJ; Thompson, AJ; Miller, DH
Differing effect of modifiable cardiovascular risk factors on intima-media thickening and plaque formation at different sites of the arterial vasculature. (2010)
Chaubey, Sanjay; Nitsch, Dorothea; Altmann, Daniel; Ebrahim, Shah
Colour Vision Impairment in Schizophrenia Is Not Explained by Impaired Attention or Cognitive Deficits. (2010)
Chu, EM; Altmann, DR; Barnes, TRE; Joyce, EM; Ron, MA
Spinal cord repair in MS: does mitochondrial metabolism play a role? (2010)
Ciccarelli, O; Altmann, DR; McLean, MA; Wheeler-Kingshott, CA; Wimpey, K; Miller, DH; Thompson, AJ
Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. (2006)
Ciccarelli, O; Behrens, TE; Altmann, DR; Orrell, RW; Howard, RS; Johansen-Berg, H; Miller, DH; Matthews, PM; Thompson, AJ
Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. (2005)
Cormican, LJ; Farooque, S; Altmann, DR; Lee, TH
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. (2004)
Dalton, Catherine M; Chard, Declan T; Davies, Gerard R; Miszkiel, Katherine A; Altmann, Dan R; Fernando, Kryshani; Plant, Gordon T; Thompson, Alan J; Miller, David H
Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. (2005)
Davies, GR; Altmann, DR; Hadjiprocopis, A; Rashid, W; Chard, DT; Griffin, CM; Tofts, PS; Barker, GJ; Kapoor, R; Thompson, AJ; Miller, DH
Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. (2005)
Davies, GR; Altmann, DR; Rashid, W; Chard, DT; Griffin, CM; Barker, GJ; Kapoor, R; Thompson, AJ; Miller, DH
Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. (2007)
Davies, GR; Hadjiprocopis, A; Altmann, DR; Chard, DT; Griffin, CM; Rashid, W; Parker, GJ; Tofts, PS; Kapoor, R; Thompson, AJ; Miller, DH
Increase in daytime symptoms is a sensitive and specific criterion for predicting corticosteroid-treated exacerbations in a clinical asthma trial. (2005)
Dennis, SM; Altmann, DR; Lee, TH
The relationship between TRUST exacerbations and morning peak expiratory flow. (2001)
Dennis, SM; Altmann, DR; Lee, TH
Additional corticosteroid use and daytime symptoms as a proxy for asthma exacerbation. (2001)
Dennis, SM; Altmann, DR; Lee, TH
Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. (2010)
Di Filippo, M; Anderson, VM; Altmann, DR; Swanton, JK; Plant, GT; Thompson, AJ; Miller, DH
Increasing cord atrophy in clinical isolated syndrome group: a 5-year study. (2006)
Drapier, S; Swanton, J; Altmann, D; Fernando, KTM; Dalton, C; Thompson, AJ; Plant, G; Miller, DH
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. (2009)
Fisniku, LK; Altmann, DR; Cercignani, M; Tozer, DJ; Chard, DT; Jackson, JS; Miszkiel, KA; Schmierer, K; Thompson, AJ; Miller, DH
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. (2008)
Fisniku, LK; Brex, PA; Altmann, DR; Miszkiel, KA; Benton, CE; Lanyon, R; Thompson, AJ; Miller, DH
Changes in brain lesion load over 20 years and subsequent brain atrophy in clinically isolated syndrome patients. (2008)
Fisniku, LK; Brex, PA; Chard, DT; Jackson, J; Altmann, D; Miszkiel, KA; Thompson, AJ; Miller, D
Disability and T2 MRI abnormalities: A 20 year follow-up of patients with relapse onset of multiple sclerosis. (2007)
Fisniku, LK; Brex, PA; Miszkiel, K; Altmann, DR; Thompson, AJ; Miller, DH
Gray matter atrophy is related to long-term disability in multiple sclerosis. (2008)
Fisniku, Leonora K; Chard, Declan T; Jackson, Jonathan S; Anderson, Valerie M; Altmann, Daniel R; Miszkiel, Katherine A; Thompson, Alan J; Miller, David H
Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. (2005)
Fletcher, Olivia; Gibson, Lorna; Johnson, Nichola; Altmann, Dan R; Holly, Jeffrey MP; Ashworth, Alan; Peto, Julian; Silva, Isabel Dos Santos
Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis. (2009)
Furby, J; Hayton, T; Altmann, D; Brenner, R; Chataway, J; Smith, KJ; Miller, DH; Kapoor, R
A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. (2010)
Furby, J; Hayton, T; Altmann, D; Brenner, R; Chataway, J; Smith, KJ; Miller, DH; Kapoor, R
Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. (2008)
Furby, J; Hayton, T; Anderson, V; Altmann, D; Brenner, R; Chataway, J; Hughes, Rac; Smith, Kj; Miller, Dh; Kapoor, R
A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis. (2006)
Furby, J; Hayton, T; Smith, KJ; Altmann, D; Brenner, R; Chataway, J; Fox, NC; Hughes, RAC; Miller, DH; Kapoor, R
White matter lesion characteristics predict types of gray matter abnormality on magnetic resonance imaging in secondary progressive multiple sclerosis. (2008)
Furby, J; Hayton, T; Smith, KJ; Altmann, D; Brenner, R; Chataway, J; Hughes, RA; Miller, D; Kapoor, R
Characteristics of Frontal and Temporal Cortex in Relation to Cognitive Dysfunction in Patients with First-Episode Psychosis. (2009)
Gutierrez, L; Wheeler-Kingshott, C; Altmann, D; Price, G; Chu, E; Leeson, V; Barnes, T; Joyce, E; Ron, M
Correlation between brain magnetisation transfer ratio and clinical disability measures in secondary progressive multiple sclerosis. (2007)
Hayton, T; Furby, J; Smith, K; Altmann, D; Brenner, R; Chataway, J; Fox, NC; Hughes, RAC; Miller, DH; Kapoor, R
Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. (2009)
Hayton, T; Furby, J; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; Hughes, RAC; Hunter, K; Tozer, DJ; Miller, DH; Kapoor, R
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine. (2011)
Hayton, T; Furby, J; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; Hunter, K; Tozer, DJ; Miller, DH; Kapoor, R
Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis. (2011)
Hayton, T; Furby, J; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; Hunter, K; Tozer, DJ; Miller, DH; Kapoor, R
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis. (2008)
Henderson, APD; Trip, SA; Schlottmann, PG; Altmann, DR; Garway-Heath, DF; Plant, GT; Miller, DH
A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. (2010)
Henderson, Andrew PD; Altmann, Daniel R; Trip, Anand S; Kallis, Constantinos; Jones, Steve J; Schlottmann, Patricio G; Garway-Heath, David F; Plant, Gordon T; Miller, David H
Early factors associated with axonal loss after optic neuritis. (2011)
Henderson, Andrew PD; Altmann, Daniel R; Trip, S Anand; Miszkiel, Katherine A; Schlottmann, Patricio G; Jones, Steve J; Garway-Heath, David F; Plant, Gordon T; Miller, David H
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. (2007)
Henderson, Andrew PD; Trip, S Anand; Schlottmann, Patricio G; Altmann, Daniel R; Garway-Heath, David F; Plant, Gordon T; Miller, David H
A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. (2010)
Henderson, Andrew PD; Trip, SA; Schlottmann, PG; Altmann, DR; Garway-Heath, DF; Plant, GT; Miller, DH
Corticosteroids do not prevent optic nerve atrophy following optic neuritis. (2003)
Hickman, SJ; Kapoor, R; Jones, SJ; Altmann, DR; Plant, GT; Miller, DH
Serial magnetization transfer imaging in acute optic neuritis. (2004)
Hickman, SJ; Toosy, AT; Jones, SJ; Altmann, DR; Miszkiel, KA; MacManus, DG; Barker, GJ; Plant, GT; Thompson, AJ; Miller, DH
A serial MRI study following optic nerve mean area in acute optic neuritis. (2004)
Hickman, Simon J; Toosy, Ahmed T; Jones, Stephen J; Altmann, Daniel R; Miszkiel, Katharine A; MacManus, David G; Barker, Gareth J; Plant, Gordon T; Thompson, Alan J; Miller, David H
Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study. (2004)
Hickman, Simon J; Toosy, Ahmed T; Miszkiel, Katherine A; Jones, Stephen J; Altmann, Daniel R; MacManus, David G; Plant, Gordon T; Thompson, Alan J; Miller, David H
Using structural and functional magnetic resonance imaging to explain visual loss at the onset of acute optic neuritis. (2008)
Jenkins, T; Mancini, L; Ciccarelli, O; Toosy, A; Altmann, D; Chappell, K; Plant, G; Miller, D; Thompson, AJ
Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity. (2009)
Jenkins, Thomas; Ciccarelli, Olga; Toosy, Ahmed; Miszkiel, Katherine; Wheeler-Kingshott, Claudia; Altmann, Daniel; Mancini, Laura; Jones, Steve; Plant, Gordon; Miller, David; Thompson, Alan
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. (2010)
Kapoor, Raju; Furby, Julian; Hayton, Thomas; Smith, Kenneth J; Altmann, Daniel R; Brenner, Robert; Chataway, Jeremy; Hughes, Richard AC; Miller, David H
Phenytoin for neuroprotection - Authors' reply. (2016)
Kapoor, Raju; Raftopoulos, Rhian; Altmann, Daniel R; Miller, David H; Hickman, Simon J
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis. (2014)
Kearney, H; Schneider, T; Yiannakas, MC; Altmann, DR; Wheeler-Kingshott, CAM; Ciccarelli, O; Miller, DH
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis. (2015)
Kearney, H; Schneider, T; Yiannakas, MC; Altmann, DR; Wheeler-Kingshott, CAM; Ciccarelli, O; Miller, DH
Improved MRI quantification of spinal cord atrophy in multiple sclerosis. (2013)
Kearney, Hugh; Yiannakas, Marios C; Abdel-Aziz, Khaled; Wheeler-Kingshott, Claudia AM; Altmann, Daniel R; Ciccarelli, Olga; Miller, David H
Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. (2008)
Khaleeli, Zhaleh; Altmann, Daniel R; Cercignani, Mara; Ciccarelli, Olga; Miller, David H; Thompson, Alan J
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord. (2005)
Laura, M; Leong, W; Murray, NMF; Ingle, G; Miszkiel, KA; Altmann, DR; Miller, DH; Reilly, MM
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis. (2005)
Lim, ET; Sellebjerg, F; Jensen, CV; Altmann, DR; Grant, D; Keir, G; Thompson, EJ; Giovannoni, G
Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic review. (2001)
Mazzaglia, G; Britton, AR; Altmann, DR; Chenet, L
Patient information study: the information preferences of people with cancer: final report to CRC. (2001)
McPherson, K; Leydon, GM; Osborne, K; Patton, R; Chaudhri, W; Altmann, D
Advances in imaging to support the development of novel therapies for multiple sclerosis. (2012)
Miller, DH; Altmann, DR; Chard, DT
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability. (2013)
Paling, David; Thade Petersen, Esben; Tozer, Daniel J; Altmann, Daniel R; Wheeler-Kingshott, Claudia AM; Kapoor, Raju; Miller, David H; Golay, Xavier
TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis. (2010)
Papadopoulos, Konstantinos; Tozer, Daniel J; Fisniku, Leonora; Altmann, Daniel R; Davies, Gerard; Rashid, Waqar; Thompson, Alan J; Miller, David H; Chard, Declan T
The challenge of measuring global fruit and vegetable intake. (2004)
Pomerleau, Joceline; Lock, Karen; McKee, Martin; Altmann, Dan R
The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. (2005)
Price, G; Bagary, MS; Cercignani, M; Altmann, DR; Ron, MA
Corrigendum to “Abnormal brain connectivity in first-episode psychosis: A diffusion MRI tractography study of the corpus callosum” [NeuroImage 35 (2007) 458–466]. (2007)
Price, Gary; Cercignani, Mara; Parker, Geoffrey JM; Altmann, Daniel R; Barnes, Thomas RE; Barker, Gareth J; Joyce, Eileen M; Ron, Maria A
Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. (2006)
Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; Thompson, AJ; Miller, DH
Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. (2007)
Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Thompson, AJ; Miller, DH
Abnormalities of cerebral perfusion in multiple sclerosis. (2004)
Rashid, W; Parkes, LM; Ingle, GT; Chard, DT; Toosy, AT; Altmann, DR; Symms, MR; Tofts, PS; Thompson, AJ; Miller, DH
Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. (2006)
Rashid, Waqar; Davies, Gerard R; Chard, Declan T; Griffin, Colette M; Altmann, Dan R; Gordon, Ros; Kapoor, Raju; Thompson, Alan J; Miller, David H
Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. (2008)
Rashid, Waqar; Hadjiprocopis, Andreas; Davies, Gerard; Griffin, Collette; Chard, Declan; Tiberio, Michaela; Altmann, Dan; Wheeler-Kingshott, Claudia; Tozer, Dan; Thompson, Alan; Miller, David H
Tumor Growth Rate Predicts Transformation-Free Survival in Adult Low-Grade Gliomas. (2008)
Rees, JH; Winston, JS; Jager, R; Benton, C; Caseiras, GB; Tofts, PS; Altmann, D; Tozer, D; Waldman, AD
Disability prediction in early PPMS using a magnetic resonance multiparameter approach. (2007)
Sastre-Garriga, J; Altmann, DR; Ingle, G; Ramio-Torrenta, L; Khadeeli, Z; McLean, MA; Miller, DH; Thompson, AJ
Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data. (2005)
Sastre-Garriga, J; Ingle, GT; Rovaris, M; Téllez, N; Jasperse, B; Altmann, DR; Benedetti, B; Stevenson, VL; Cercignani, M; Leary, SM; Barkhof, F; Brochet, B; Dousset, V; Filippi, M; Montalban, X; Kalkers, NF; Polman, CH; Rovira, A; Miller, DH; Thompson, AJ
Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. (2004)
Schmierer, Klaus; Altmann, Daniel R; Kassim, Nadja; Kitzler, Hagen; Kerskens, Christian M; Doege, Claudia A; Aktas, Orhan; Lünemann, Jan D; Miller, David H; Zipp, Frauke; Villringer, Arno
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. (2004)
Schmierer, Klaus; Scaravilli, Francesco; Altmann, Daniel R; Barker, Gareth J; Miller, David H
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. (2007)
Schmierer, Klaus; Tozer, Daniel J; Scaravilli, Francesco; Altmann, Daniel R; Barker, Gareth J; Tofts, Paul S; Miller, David H
Subtle blood brain barrier leakage in non-enhancing lesions in relapsing multiple sclerosis: multi-centre study of patients in a therapeutic trial. (2005)
Soon, D; Altmann, DR; Barkhof, F; Fernando, KTM; Giovannoni, G; Gray, B; O'Connor, PW; Panzara, MA; Polman, C; Miller, DH
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. (2007)
Soon, D; Tozer, DJ; Altmann, DR; Tofts, PS; Miller, DH
A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. (2007)
Soon, Derek; Altmann, Daniel R; Fernando, Kryshani TM; Giovannoni, Garin; Barkhof, Frederick; Polman, Chris H; O'Connor, Paul; Gray, Bruce; Panzara, Michael; Miller, David H
Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. (2010)
Swanton, JK; Fernando, KT; Dalton, CM; Miszkiel, KA; Altmann, DR; Plant, GT; Thompson, AJ; Miller, DH
Early MRI in optic neuritis: the risk for disability. (2009)
Swanton, JK; Fernando, KT; Dalton, CM; Miszkiel, KA; Altmann, DR; Plant, GT; Thompson, AJ; Miller, DH
Predicting disability in patients presenting with optic neuritis: the role of early magnetic resonance imaging parameters. (2008)
Swanton, JK; Kryshani, FT; Dalton, C; Miszkiel, KA; Altmann, DR; Plant, G; Chard, DT; Thompson, AJ; Miller, DH
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. (2007)
Swanton, Josephine K; Rovira, Alex; Tintore, Mar; Altmann, Daniel R; Barkhof, Frederik; Filippi, Massimo; Huerga, Elena; Miszkiel, Katherine A; Plant, Gordon T; Polman, Chris; Rovaris, Marco; Thompson, Alan J; Montalban, Xavier; Miller, David H
Bone mineral density in institutionalised patients with refractory epilepsy. (2007)
Swanton, Josephine; Simister, Robert; Altmann, Daniel; Watts, Hilary; Keen, Richard; Duncan, John S; Koepp, Matthias J
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. (2005)
Tiberio, M; Chard, DT; Altmann, DR; Davies, G; Griffin, CM; McLean, MA; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Miller, DH
Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. (2005)
Tiberio, M; Chard, DT; Altmann, DR; Davies, G; Griffin, CM; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Miller, DH
Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas. (2006)
Tofts, Paul S; Benton, Christopher E; Weil, Rimona S; Tozer, Daniel J; Altmann, Daniel R; Jäger, H Rolf; Waldman, Adam D; Rees, Jeremy H
Adaptive cortical plasticity in higher visual areas after acute optic neuritis. (2005)
Toosy, Ahmed T; Hickman, Simon J; Miszkiel, Katherine A; Jones, Stephen J; Plant, Gordon T; Altmann, Daniel R; Barker, Gareth J; Miller, David H; Thompson, Alan J
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis. (2014)
Toosy, Ahmed T; Kou, Nancy; Altmann, Daniel; Wheeler-Kingshott, Claudia AM; Thompson, Alan J; Ciccarelli, Olga
Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. (2005)
Tozer, DJ; Davies, GR; Altmann, DR; Miller, DH; Tofts, PS
Principal component and linear discriminant analysis of T1 histograms of white and grey matter in multiple sclerosis. (2006)
Tozer, Daniel J; Davies, Gerard R; Altmann, Daniel R; Miller, David H; Tofts, Paul S
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. (2005)
Trip, S Anand; Schlottmann, Patricio G; Jones, Stephen J; Altmann, Daniel R; Garway-Heath, David F; Thompson, Alan J; Plant, Gordon T; Miller, David H
Scanning laser polarimetry quantification of retinal nerve fiber layer thinning following optic neuritis. (2010)
Trip, S Anand; Schlottmann, Patricio G; Jones, Stephen J; Kallis, Constantinos; Altmann, Daniel R; Garway-Heath, David F; Thompson, Alan J; Plant, Gordon T; Miller, David H
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS. (2010)
Tur, C; Khaleeli, Z; Ciccarelli, O; Altmann, DR; Cercignani, M; Miller, DH; Thompson, AJ
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. (2011)
Tur, C; Penny, S; Khaleeli, Z; Altmann, DR; Cipolotti, L; Ron, M; Thompson, AJ; Ciccarelli, O
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS. (2014)
Tur, Carmen; Ramagopalan, Sreeram; Altmann, Daniel R; Bodini, Benedetta; Cercignani, Mara; Khaleeli, Zhaleh; Miller, David H; Thompson, Alan J; Ciccarelli, Olga
IUD expulsion and its socio-demographic determinants in China. (2002)
Wang, D; Altmann, DR
Socio-demographic determinants of intrauterine device use and failure in China. (2002)
Wang, Duolao; Altmann, Dan R
'Optimal' levels of alcohol consumption for men and women at different ages. (2003)
White, IR; Altmann, DR; Nanchahal, K
Models of alcohol consumption and mortality for men and women at different ages [Conference presentation]. (2001)
White, IR; Altmann, DR; Nanchahal, K
Mortality in England and Wales attributable to any drinking, drinking above sensible limits and drinking above lowest-risk level. (2004)
White, Ian R; Altmann, Dan R; Nanchahal, Kiran
Early brain atrophy and lesion load measures relate to clinical status after six years in patients with clinically isolated syndromes. (2008)
di Filippo, M; Anderson, VM; Altmann, D; Swanton, JK; Plant, GT; Thompson, AJ; Miller, DH
Public
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. (2015)
Abdel-Aziz, Khaled; Schneider, Torben; Solanky, Bhavana S; Yiannakas, Marios C; Altmann, Dan R; Wheeler-Kingshott, Claudia AM; Peters, Amy L; Day, Brian L; Thompson, Alan J; Ciccarelli, Olga
description
Age related changes in metabolite concentrations in the normal spinal cord. (2014)
Abdel-Aziz, Khaled; Solanky, Bhavana S; Yiannakas, Marios C; Altmann, Daniel R; Wheeler-Kingshott, Claudia AM; Thompson, Alan J; Ciccarelli, Olga
Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis. (2017)
Afolabi, Dayo; Albor, Christo; Zalewski, Lukasz; Altmann, Dan R; Baker, David; Schmierer, Klaus
White and gray matter damage in primary progressive MS: The chicken or the egg? (2015)
Bodini, Benedetta; Chard, Declan; Altmann, Daniel R; Tozer, Daniel; Miller, David H; Thompson, Alan J; Wheeler-Kingshott, Claudia; Ciccarelli, Olga
description
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. (2016)
Brownlee, WJ; Altmann, DR; Alves Da Mota, P; Swanton, JK; Miszkiel, KA; Wheeler-Kingshott, CG; Ciccarelli, O; Miller, DH
description
Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes. (2016)
Brownlee, WJ; Miszkiel, KA; Altmann, DR; Ciccarelli, O; Miller, DH
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. (2019)
Brownlee, Wallace J; Altmann, Dan R; Prados, Ferran; Miszkiel, Katherine A; Eshaghi, Arman; Gandini Wheeler-Kingshott, Claudia AM; Barkhof, Frederik; Ciccarelli, Olga
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. (2014)
Brownlee, Wallace J; Swanton, Josephine K; Altmann, Daniel R; Ciccarelli, Olga; Miller, David H
FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? (2017)
Campion, T; Smith, RJP; Altmann, DR; Brito, GC; Turner, BP; Evanson, J; George, IC; Sati, P; Reich, DS; Miquel, ME; Schmierer, K
Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex. (2017)
Carassiti, D; Altmann, DR; Petrova, N; Pakkenberg, B; Scaravilli, F; Schmierer, K
A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes. (2019)
Chung, Karen K; Altmann, Daniel; Barkhof, Frederik; Miszkiel, Katherine; Brex, Peter A; O'Riordan, Jonathan; Ebner, Michael; Prados, Ferran; Cardoso, M Jorge; Vercauteren, Tom; Ourselin, Sebastien; Thompson, Alan; Ciccarelli, Olga; Chard, Declan T
Single-subject structural cortical networks in clinically isolated syndrome. (2019)
Collorone, Sara; Prados, Ferran; Hagens, Marloes Hj; Tur, Carmen; Kanber, Baris; Sudre, Carole H; Lukas, Carsten; Gasperini, Claudio; Oreja-Guevara, Celia; Andelova, Micaela; Ciccarelli, Olga; Wattjes, Mike P; Ourselin, Sebastian; Altmann, Daniel R; Tijms, Betty M; Barkhof, Frederik; Toosy, Ahmed T; MAGNIMS Study Group
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. (2012)
Connick, Peter; Kolappan, Madhan; Crawley, Charles; Webber, Daniel J; Patani, Rickie; Michell, Andrew W; Du, Ming-Qing; Luan, Shi-Lu; Altmann, Daniel R; Thompson, Alan J; Compston, Alastair; Scott, Michael A; Miller, David H; Chandran, Siddharthan
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. (2011)
Connick, Peter; Kolappan, Madhan; Patani, Rickie; Scott, Michael A; Crawley, Charles; He, Xiao-Ling; Richardson, Karen; Barber, Kelly; Webber, Daniel J; Wheeler-Kingshott, Claudia AM; Tozer, Daniel J; Samson, Rebecca S; Thomas, David L; Du, Ming-Qing; Luan, Shi L; Michell, Andrew W; Altmann, Daniel R; Thompson, Alan J; Miller, David H; Compston, Alastair; Chandran, Siddharthan
Deep gray matter volume loss drives disability worsening in multiple sclerosis. (2018)
Eshaghi, Arman; Prados, Ferran; Brownlee, Wallace J; Altmann, Daniel R; Tur, Carmen; Cardoso, M Jorge; De Angelis, Floriana; van de Pavert, Steven H; Cawley, Niamh; De Stefano, Nicola; Stromillo, M Laura; Battaglini, Marco; Ruggieri, Serena; Gasperini, Claudio; Filippi, Massimo; Rocca, Maria A; Rovira, Alex; Sastre-Garriga, Jaume; Vrenken, Hugo; Leurs, Cyra E; Killestein, Joep; Pirpamer, Lukas; Enzinger, Christian; Ourselin, Sebastien; Wheeler-Kingshott, Claudia AM Gandini; Chard, Declan; Thompson, Alan J; Alexander, Daniel C; Barkhof, Frederik; Ciccarelli, Olga; MAGNIMS study group
MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. (2013)
Freund, Patrick; Weiskopf, Nikolaus; Ashburner, John; Wolf, Katharina; Sutter, Reto; Altmann, Daniel R; Friston, Karl; Thompson, Alan; Curt, Armin
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. (2018)
Gold, Julian; Marta, Monica; Meier, Ute C; Christensen, Tove; Miller, David; Altmann, Daniel; Holden, David; Bianchi, Lucia; Adiutori, Rocco; MacManus, David; Yousry, Tarek; Schmierer, Klaus; Turner, Benjamin; Giovannoni, Gavin
Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. (2010)
Gorgoraptis, Nikos; Wheeler-Kingshott, Claudia AM; Jenkins, Thomas M; Altmann, Daniel R; Miller, David H; Thompson, Alan J; Ciccarelli, Olga
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. (2010)
Gutiérrez-Galve, Leticia; Wheeler-Kingshott, Claudia AM; Altmann, Daniel R; Price, Gary; Chu, Elvina M; Leeson, Verity C; Lobo, Antonio; Barker, Gareth J; Barnes, Thomas RE; Joyce, Eileen M; Ron, María A
picture_as_pdf
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis. (2015)
Kearney, Hugh; Miszkiel, Katherine A; Yiannakas, Marios C; Altmann, Daniel R; Ciccarelli, Olga; Miller, David H
Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a. (2004)
Lim, Ee Tuan; Petzold, Axel; Leary, Siobhan M; Altmann, Daniel R; Keir, Geoff; Thompson, Ed J; Miller, David H; Thompson, Alan J; Giovannoni, Gavin
The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. (2005)
Lock, Karen; Pomerleau, Joceline; Causer, Louise; Altmann, Dan R; McKee, Martin
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine. (2015)
Pakpoor, Julia; Disanto, Giulio; Altmann, Daniel R; Pavitt, Sue; Turner, Benjamin P; Marta, Monica; Juliusson, Gunnar; Baker, David; Chataway, Jeremy; Schmierer, Klaus
Motor network efficiency and disability in multiple sclerosis. (2015)
Pardini, Matteo; Yaldizli, Özgür; Sethi, Varun; Muhlert, Nils; Liu, Zheng; Samson, Rebecca S; Altmann, Daniel R; Ron, Maria A; Wheeler-Kingshott, Claudia AM; Miller, David H; Chard, Declan T
['material/summary:fileicon_application/msword' not defined]
Axonal loss in the multiple sclerosis spinal cord revisited. (2017)
Petrova, N; Carassiti, D; Altmann, DR; Baker, D; Schmierer, K
White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. (2008)
Price, Gary; Cercignani, Mara; Parker, Geoffrey JM; Altmann, Daniel R; Barnes, Thomas RE; Barker, Gareth J; Joyce, Eileen M; Ron, Maria A
Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. (2006)
Price, Gary; Cercignani, Mara; Parker, Geoffrey JM; Altmann, Daniel R; Barnes, Thomas RE; Barker, Gareth J; Joyce, Eileen M; Ron, Maria A
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. (2016)
Raftopoulos, Rhian; Hickman, Simon J; Toosy, Ahmed; Sharrack, Basil; Mallik, Shahrukh; Paling, David; Altmann, Daniel R; Yiannakas, Marios C; Malladi, Prasad; Sheridan, Rose; Sarrigiannis, Ptolemaios G; Hoggard, Nigel; Koltzenburg, Martin; Gandini Wheeler-Kingshott, Claudia AM; Schmierer, Klaus; Giovannoni, Gavin; Miller, David H; Kapoor, Raju
description
Diffusion tensor imaging of post mortem multiple sclerosis brain. (2006)
Schmierer, Klaus; Wheeler-Kingshott, Claudia AM; Boulby, Phil A; Scaravilli, Francesco; Altmann, Daniel R; Barker, Gareth J; Tofts, Paul S; Miller, David H
picture_as_pdf
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis. (2015)
Sethi, Varun; Yousry, Tarek; Muhlert, Nils; Tozer, Daniel J; Altmann, Daniel; Ron, Maria; Wheeler-Kingshott, Claudia; Miller, David H; Chard, Declan T
description
Structural cortical network reorganization associated with early conversion to multiple sclerosis. (2018)
Tur, C; Eshaghi, A; Altmann, DR; Jenkins, TM; Prados, F; Grussu, F; Charalambous, T; Schmidt, A; Ourselin, S; Clayden, JD; Wheeler-Kingshott, CAMG; Thompson, AJ; Ciccarelli, O; Toosy, AT
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis. (2016)
Tur, Carmen; Goodkin, Olivia; Altmann, Daniel R; Jenkins, Thomas M; Miszkiel, Katherine; Mirigliani, Alessia; Fini, Camilla; Gandini Wheeler-Kingshott, Claudia AM; Thompson, Alan J; Ciccarelli, Olga; Toosy, Ahmed T
description
A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis. (2019)
Tur, Carmen; Grussu, Francesco; Prados, Ferran; Charalambous, Thalis; Collorone, Sara; Kanber, Baris; Cawley, Niamh; Altmann, Daniel R; Ourselin, Sébastien; Barkhof, Frederik; Clayden, Jonathan D; Toosy, Ahmed T; Wheeler-Kingshott, Claudia Am Gandini; Ciccarelli, Olga
Clinical relevance of cortical network dynamics in early primary progressive MS. (2019)
Tur, Carmen; Kanber, Baris; Eshaghi, Arman; Altmann, Dan R; Khaleeli, Zhaleh; Prados, Ferran; Ourselin, Sebastian; Thompson, Alan J; Gandini Wheeler-Kingshott, Claudia Am; Toosy, Ahmed T; Ciccarelli, Olga
Alcohol consumption and mortality: modelling risks for men and women at different ages. (2002)
White, Ian R; Altmann, Dan R; Nanchahal, Kiran
Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. (2003)
Woodcock, Ashley; Forster, Louise; Matthews, Edward; Martin, Jeannett; Letley, Louise; Vickers, Madge; Britton, John; Strachan, David; Howarth, Peter; Altmann, Daniel; Frost, Christopher; Custovic, Adnan; Medical Research Council General Practice Research Framework
Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T. (2016)
Yiannakas, Marios C; Grussu, Francesco; Louka, Polymnia; Prados, Ferran; Samson, Rebecca S; Battiston, Marco; Altmann, Daniel R; Ourselin, Sebastien; Miller, David H; Gandini Wheeler-Kingshott, Claudia AM
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis. (2015)
Yiannakas, Marios C; Mustafa, Ahmed M; De Leener, Benjamin; Kearney, Hugh; Tur, Carmen; Altmann, Daniel R; De Angelis, Floriana; Plantone, Domenico; Ciccarelli, Olga; Miller, David H; Cohen-Adad, Julien; Gandini Wheeler-Kingshott, Claudia AM
ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI. (2013)
Yiannakas, Marios C; Tozer, Daniel J; Schmierer, Klaus; Chard, Declan T; Anderson, Valerie M; Altmann, Daniel R; Miller, David H; Wheeler-Kingshott, Claudia AM
Progressive neurodegeneration following spinal cord injury: Implications for clinical trials. (2018)
Ziegler, Gabriel; Grabher, Patrick; Thompson, Alan; Altmann, Daniel; Hupp, Markus; Ashburner, John; Friston, Karl; Weiskopf, Nikolaus; Curt, Armin; Freund, Patrick